EDITAS MEDICINE, INC. Available-for-sale Securities, Gross Realized Gain (Loss)
EDITAS MEDICINE, INC. (EDIT) reported Available-for-sale Securities, Gross Realized Gain (Loss) of $0 for the 12-month period ending 2017-12-31, per its 10-K filed 2018-03-08.
Discontinued › Income Statement › Other Income
us-gaap:AvailableForSaleSecuritiesGrossRealizedGainLossNet · last filed 2018-03-08
- EDITAS MEDICINE, INC. available-for-sale securities, gross realized gain (loss) for the quarter ending 2017-12-31 was $0.00.
- EDITAS MEDICINE, INC. available-for-sale securities, gross realized gain (loss) for the quarter ending 2017-09-30 was $0.00.
- EDITAS MEDICINE, INC. available-for-sale securities, gross realized gain (loss) for the quarter ending 2016-12-31 was $0.00.
- EDITAS MEDICINE, INC. available-for-sale securities, gross realized gain (loss) for the quarter ending 2016-09-30 was $0.00.
- EDITAS MEDICINE, INC. available-for-sale securities, gross realized gain (loss) for fiscal 2017 was $0.00.
- EDITAS MEDICINE, INC. available-for-sale securities, gross realized gain (loss) for fiscal 2016 was $0.00.
| Period end | Available-for-sale Securities, Gross Realized Gain (Loss) 3 month | Available-for-sale Securities, Gross Realized Gain (Loss) 6 month | Available-for-sale Securities, Gross Realized Gain (Loss) 9 month | Available-for-sale Securities, Gross Realized Gain (Loss) 12 month |
|---|---|---|---|---|
| 2017-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-08 | $0.00 derived: sum of 2 quarters · filed 2018-03-08 | $0.00 10-K · filed 2018-03-08 | |
| 2017-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-08 | $0.00 10-Q · filed 2017-11-08 | ||
| 2017-06-30 | $0.00 10-Q · filed 2017-08-09 | |||
| 2016-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-08 | $0.00 derived: sum of 2 quarters · filed 2018-03-08 | $0.00 10-K · filed 2018-03-08 | |
| 2016-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-08 | $0.00 10-Q · filed 2017-11-08 | ||
| 2016-06-30 | $0.00 10-Q · filed 2017-08-09 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Kyverna Therapeutics, Inc. (KYTX) | United States | $0.434B | -3.60 |
| Scribe Therapeutics, Inc. (SCTX) | United States | $0.410B | |
| Eikon Therapeutics, Inc. (EIKN) | United States | $0.446B | |
| Zura Bio Ltd (ZURA) | $0.398B | -6.56 | |
| Surrozen, Inc./DE (SRZN) | United States | $0.395B | |
| AGENUS INC (AGEN) | United States | $0.383B | 1.41 |
| Tectonic Therapeutic, Inc. (TECX) | United States | $0.469B | -7.68 |
| C4 Therapeutics, Inc. (CCCC) | United States | $0.373B | -5.65 |
| FENNEC PHARMACEUTICALS INC. (FENC) | United States | $0.371B | -115.85 |
| REGENXBIO Inc. (RGNX) | United States | $0.477B | -3.30 |